State Group Insurance Program Coverage of Standard Fertility Preservation Services
Summary
CS/HB 677 requires the Florida Department of Management Services to provide coverage under certain state group health insurance plans for medically necessary standard fertility retrieval and preservation services when cancer treatment may directly or indirectly cause iatrogenic infertility. The bill applies to policies issued on or after January 1, 2026, and covers retrieval and preservation of sperm and oocyte materials, including ovarian tissue, sperm, and oocyte cryopreservation, so long as the services are consistent with nationally recognized clinical practice guidelines.
The bill limits the duration of covered storage and retrieval expenses to three years after the procedure that created the risk of infertility, or until the covered person is no longer enrolled in the state group health plan, whichever comes first. It also bars the plan from requiring preauthorization for these services, while allowing the plan to apply maximum benefit limits and the same deductible, copayment, and coinsurance rules that apply to other covered services. The act takes effect July 1, 2025.
Impact
The bill amends section 110.12303, Florida Statutes, by adding a new state-group-insurance benefit mandate for fertility preservation tied to cancer treatment. It expands the required benefits available to eligible state employees and other participants in the state group health insurance program, and it defines key terms such as iatrogenic infertility and standard fertility retrieval and preservation services. The measure affects the Department of Management Services, state health plan administrators, and covered employees who face fertility-threatening medical treatment.
Sentiment
The bill appears to have been broadly supported in the Legislature. It passed multiple House committees unanimously and cleared the House on a 115-0 vote, indicating strong bipartisan approval in that chamber. In the Senate, it also advanced on third reading with a substantial majority, though not unanimously, suggesting overall favorable sentiment with some limited dissent.
Contention
The main policy issues are the scope and cost of the new coverage mandate. The bill requires coverage only for fertility preservation connected to cancer treatment and only for services consistent with recognized clinical guidelines, which may have been intended to limit cost and eligibility concerns. It also allows maximum benefit caps and standard cost-sharing, while prohibiting preauthorization, reflecting a balance between access for patients and administrative or fiscal concerns for the state plan. The small number of Senate nays suggests some members may have objected to the insurance mandate, cost exposure, or the breadth of required benefits.